Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2022. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
4687738019 | Etamsylate and tranexamic acid only product in oral dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
4687739010 | Product containing only etamsylate and tranexamic acid in oral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
5305231000052113 | läkemedel som endast innehåller etamsylat och tranexamsyra, oral läkemedelsform | sv | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Etamsylate and tranexamic acid only product in oral dose form | Is a | Product containing only etamsylate and tranexamic acid (medicinal product) | true | Inferred relationship | Some | ||
Etamsylate and tranexamic acid only product in oral dose form | Is a | Etamsylate- and tranexamic acid-containing product in oral dose form | true | Inferred relationship | Some | ||
Etamsylate and tranexamic acid only product in oral dose form | Has manufactured dose form | Oral dose form | true | Inferred relationship | Some | ||
Etamsylate and tranexamic acid only product in oral dose form | Plays role | Hemostatic therapeutic role (role) | true | Inferred relationship | Some | ||
Etamsylate and tranexamic acid only product in oral dose form | Has active ingredient | Tranexamic acid (substance) | true | Inferred relationship | Some | 1 | |
Etamsylate and tranexamic acid only product in oral dose form | Has active ingredient | Etamsylate (substance) | true | Inferred relationship | Some | 2 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Etamsylate 250 mg and tranexamic acid 250 mg oral tablet | Is a | True | Etamsylate and tranexamic acid only product in oral dose form | Inferred relationship | Some |
This concept is not in any reference sets